Bahrain approved the registration of the Sinopharm Group Co Ltd. vaccine against the covid-19, about a week after the United Arab Emirates registered the Chinese-made vaccine. Bahrain said it approved the use of a Chinese coronavirus vaccine, after its earlier approval of a vaccine made by Pfizer and its German partner BioNTech.
In a statement on Sunday, the National Health Regulatory Authority said, “Results from Phase III clinical trials showed an 86% efficacy rate, a 99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of Covid-19." The country has taken part in phase III clinical trials, in which more than 7,700 volunteers signed up. Bahrain had previously approved the emergency use of the vaccine, which was provided to frontline workers who are in contact with covid-19 patients.
The UAE registered the Sinopharm vaccine after finding it had a 86% efficacy rate, paving the way for full public use and allowing for a re-opening of the economy. The efforts of inoculation against the coronavirus after receiving the first shipments of Sinopharm vaccine.
Also Read:
US approves Pfizer BioNTech vaccine for Pilots, air traffic controllers
Shops will be closed in Germany from Dec 16 to Jan 10, govt proposed draft